News
Medpage Today on MSN16h
Subcutaneous Lecanemab Maintenance Dosing for Alzheimer's Supported by New DataTORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...
As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback